S O Marx, A R Marks. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angioplasty, Balloon, Coronary/adverse effectsAnimalsCalcineurin InhibitorsCarrier Proteins/metabolismCell Cycle Proteins/metabolismCell Division/drug effectsCell Movement/drug effectsClinical Trials as TopicClopidogrelCoronary Artery Disease/surgeryCyclin-Dependent Kinase Inhibitor p27Down-Regulation/drug effectsGraft Occlusion, Vascular/diagnosisGraft Occlusion, Vascular/etiologyGraft Occlusion, Vascular/prevention & controlHumansHyperplasia/diagnosisHyperplasia/prevention & controlMacromolecular SubstancesPhosphotransferases (Alcohol Group Acceptor)Platelet Aggregation Inhibitors/therapeutic useSignal Transduction/drug effectsSirolimus/metabolismSirolimus/therapeutic useStents/adverse effectsTOR Serine-Threonine KinasesTacrolimus/pharmacologyTacrolimus Binding Protein 1A/metabolismTiclopidine/analogs & derivativesTiclopidine/therapeutic useTumor Suppressor ProteinsTunica Media/drug effectsTunica Media/pathologyVascular Patency/drug effects
Substances: See more » Calcineurin InhibitorsCarrier ProteinsCell Cycle ProteinsMacromolecular SubstancesPlatelet Aggregation InhibitorsTumor Suppressor ProteinsCyclin-Dependent Kinase Inhibitor p27ClopidogrelPhosphotransferases (Alcohol Group Acceptor)MTOR protein, humanTOR Serine-Threonine KinasesTacrolimus Binding Protein 1ATiclopidineSirolimusTacrolimus
Year: 2001 PMID: 11514367 DOI: 10.1161/01.cir.104.8.852
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690